Program 01
Mitochondrial Field Effect
Do early metabolic stress states define a pre-tumor field that enables cancer initiation?
Why This Program
The premise behind Program 01.
Breast cancer in young women often arises without a single dominant driver mutation, instead emerging from distributed, system-level stress across tissue environments. Increasing evidence suggests metabolic and mitochondrial dysfunction may precede visible disease, shaping cellular fitness, immune restraint, and tissue regulation.
These early alterations are not confined to isolated cells but reflect a broader field effect within normal-appearing tissue, in which persistent metabolic stress creates a permissive environment for abnormal cells to survive and proliferate.
What We Mean
Defining mitochondrial field effect.
We define the mitochondrial field effect as a spatially and temporally distributed state of metabolic stress in tissue that precedes tumor formation, influencing whether abnormal cells are contained or allowed to progress.
- Mitochondrial dysfunction and metabolic signaling — Altered energy utilization, redox imbalance, and stress signaling pathways that shape early cellular stress states.
- Field-level tissue and regulatory changes — Normal-appearing tissue with underlying metabolic disruption, impaired immune surveillance, and weakened tissue-level restraint.
- Integration with systemic influences — Hormonal cycling, environmental exposures, and developmental timing that modulate tissue stress and recovery dynamics.
Rather than focusing solely on tumor cells, this program examines how stressed tissue ecosystems create the conditions for tumor initiation—positioning early biology as a field phenomenon rather than a localized event.